Adageis: Revolutionizing Value-Based Care with AI Technology
Summary
Full Article
What is Adageis?
Adageis is a healthcare technology company that provides AI-powered tools to clinics and medical groups to track financial outcomes tied to quality care, facilitating a shift from fee-for-service to value-based care models.
How does Adageis help medical providers?
Adageis helps providers by deciphering complex insurance contracts to maximize reimbursements, integrating with electronic health record systems to identify high-risk patients and care gaps, and visualizing revenue trends over time.
What is the ProActive Care platform?
The ProActive Care platform, rebranded as a fintech AI solution by Adageis, targets the complexity of insurance contracts to clarify how providers are rewarded for meeting care quality benchmarks.
Who can benefit from Adageis’s solutions?
Small and independent medical practices, clinics, and medical groups looking to transition to value-based care models and improve their financial outcomes can benefit from Adageis’s solutions.
Where can I find more information about Adageis?
More information about Adageis is available in the company’s newsroom at https://ibn.fm/Adageis and on their website Adageis.
Why is the shift to value-based care important?
The shift to value-based care is important because it rewards providers for the quality of care delivered rather than the quantity, encouraging improvements in patient outcomes and more efficient use of resources.
How does Adageis integrate with existing systems?
Adageis’s software integrates smoothly with major electronic health record systems, allowing providers to easily identify high-risk patients and care gaps without disrupting their current workflows.
What are the future plans for Adageis?
Adageis is continuously working with investors to expand its offerings for a growing list of small and independent practices, aiming to further support the healthcare industry’s transition to value-based care.
This story is based on an article that was registered on the blockchain. The original source content used for this article is located at InvestorBrandNetwork (IBN)
Article Control ID: 123361